Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic
reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical
name is ...
(KLA-drih-bean). Trade name: Leustatin<sup>TM</sup> Other names: 2-CdA, 2-
Chlorodeoxyadenosine. Cladribine is the generic name for the trade name drug
Jun 15, 2016 ... Cladribine: learn about side effects, dosage, special precautions, and more on
Sep 11, 2015 ... Cladribine is a type of chemotherapy that belongs to a class of drugs called
antimetabolites. These medications are taken up by cells and are ...
Find out more about cladribine (Leustat ®, LITAK ®), a chemotherapy drug used
to treat hairy cell leukaemia and B-cell chronic lymphocytic leukaemia (CLL)
Apr 12, 2016 ... Find a comprehensive guide to possible side effects including common and rare
side effects when taking Leustatin (Cladribine Injection For ...
WARNING. LEUSTATIN (cladribine) Injection should be administered under the
supervision of a qualified physician experienced in the use of antineoplastic ...
Cladribine mechanism of action. 2-CdA enters the cell through an efficient
transport system. Cladribine is resistant to deamination by ADA. The high DCK to
My father 60 years, was given 5-day Cladribine from March 30-April 3. His blood
counts almost after 2 months are around TLC- 2000, Hg- 8.9, Platelets- 52000, ...
Clin Neuropharmacol. 2011 Jan-Feb;34(1):28-35. doi: 10.1097/WNF.
0b013e318204cd90. Cladribine: mode of action and implications for treatment of